Cash & equivalents increased 46.4%
Cash & equivalents changed +46.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +46.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +36.8% from the comparable as-filed period.
Operating income changed +44.8% from the comparable as-filed period.
Operating margin changed +455 basis points from the comparable as-filed period.
Gross margin changed +269 basis points from the comparable as-filed period.
Gross profit changed +17.3% from the comparable as-filed period.
Revenue changed +12.2% from the comparable as-filed period.
Inventory changed +6.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +7.3% from the comparable as-filed period.
Selling, general & administrative changed -2.2% from the comparable as-filed period.
Stock-based compensation changed -1.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.